Genmab News

Genmab News

Date Title View
Jul 09, 2019
Genmab Commences Public Offering of American Depositary Shares (ADSs) in the United States
190709_CA32_Launch Announcement
Jul 08, 2019
Genmab Announces Positive Topline Results in the Phase II GRIFFIN Study of Transplant Eligible, Newly Diagnosed Patients with Multiple Myeloma Treated with Daratumumab in Combination with Lenalidomide, Bortezomib, and Dexamethasone
190708_CA31_GRIFFIN Data
Jun 27, 2019
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
190627_CA30_MAIA Approval
Jun 26, 2019
Genmab A/S has published its Articles of Association
Articles of Association - June 25 2019 (UK)
Jun 25, 2019
Major Shareholder Announcement
190625_CA_29_Major Shareholder Announcement Blackrock
Jun 25, 2019
Capital Increase in Genmab as a Result of Employee Warrant Exercise
190625_CA28_Warrant Exercise
Jun 19, 2019
Major Shareholder Announcement
190619_CA_27_Major Shareholder Announcement Blackrock
Jun 19, 2019
Major Shareholder Announcement
190619_CA_26_Major_Shareholder_Blackrock
Jun 13, 2019
Genmab A/S has published its Articles of Association
Articles of Association - June 6, 2019 (UK)
Jun 11, 2019
Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38
190611_CA25_HexaBody-CD38
Jun 06, 2019
Grant of Restricted Stock Units and Warrants to Employees in Genmab
190606_CA24_Warrant Grant
May 30, 2019
U.S. FDA Grants Priority Review for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
190530_CA23_CASSIOPEIA PDUFA priority review
May 28, 2019
Genmab Files Registration Statement in the United States for a Proposed Public Offering of American Depositary Shares (ADSs) and Applies for Listing of the ADSs on Nasdaq
190528_CA22_Registration Statement Filing
May 16, 2019
Genmab Announces Data to be Presented at 24th EHA Annual Congress
190516_i07MR_EHA Curtain Raiser
May 15, 2019
Genmab A/S has published its Articles of Association
Articles of Association - May 14, 2019 (UK)
May 14, 2019
Capital Increase in Genmab as a Result of Employee Warrant Exercise
2019.05.14_21CA_Warrant Exercise
May 08, 2019
Genmab Announces Financial Results for the First Quarter of 2019
190508_CA20_Q1 2019 Interim Report
Apr 17, 2019
Genmab Announces Data to be Presented at 2019 ASCO Annual Meeting
i06_190417_MR_ASCO Curtain Raiser
Apr 16, 2019
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2019
190416_19_CA_Dara Q1 Sales
Apr 05, 2019
Genmab Announces Submission of Supplemental New Drug Application in Japan for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
190405_i05_MAIA Japan submission
Apr 03, 2019
Genmab A/S has published its Articles of Association
Articles of Association - April 2, 2019 (UK)
Apr 03, 2019
Genmab Announces Phase III Study Exploring Daratumumab as Maintenance Treatment in Newly Diagnosed Multiple Myeloma
190403_CA_18_3021 Study Start
Apr 02, 2019
Capital Increase in Genmab as a Result of Employee Warrant Exercise
190402_CA17_Warrant Exercise
Apr 02, 2019
Genmab to Present at the H.C. Wainwright & Co. Global Life Sciences Conference
190402_i04_HCWainwright
Apr 02, 2019
Genmab A/S has published its Articles of Association
Articles of Association - March 29, 2019 (UK)